CompletedNot Applicable

Use Of Pet Therapy In Chıldren Receıvıng Nebulızer Treatment

Turkey (Türkiye)60 participantsStarted 2025-02-01

Plain-language summary

The use of nebulizers in children is one of the most common noninvasive methods used in respiratory system diseases. This application can cause anxiety and stress in children in hospital environments, especially in emergency departments. Our aim in this study is to evaluate the effect of pet therapy on anxiety, pulse and saturation in children between the ages of 3-6 who receive nebulizer treatment in units such as emergency departments.

Who can participate

Age range3 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Receiving inhalation therapy as an outpatient in the emergency department * Between 3 and 6 years of age (determined as the age range in which children can communicate visually and emotionally) * Parents must have received nebulizer training before the procedure/nurse-assisted treatment if this is the first procedure * No visual impairment (for communication in pet therapy) * No congenital cardiac disease (for homogeneous data in pulse and SpO2 monitoring) * Agreeing to participate in the study Exclusion criteria for the study: * Children under 3 and over 6 * Parents and children who do not agree to participate in the study

What they're measuring

Scale for Assessing Children's Emotional Expression

Timeframe: The treatment period for the sick child in the emergency unit covers an average of 20-30 minutes during which time he/she receives nebulization.

Trial details

NCT IDNCT07082907

SponsorRecep Tayyip Erdogan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Respiratory Disease trials